Sentence examples for modifying the conformation from inspiring English sources

This could indicate that integration of TC in the N-terminal of the oleosin impaired the B12 binding capacity of the chimer protein, probably by modifying the conformation of the C-terminal domain of TC [22].

RF3 was modeled interacting with RF1 in the E. coli 70S ribosome by modifying the conformation of RF3 first to roughly fit the corresponding cryo-EM density map.

Therefore, by modifying the conformation of p53 in response to apoptotic stress, it is reasonable to state that Pin1 can also modulate Che-1 dissociation from the tumor suppressor.

Our data demonstrate that the carboxy-terminus of ClC channels modifies the conformation of the outer pore vestibule.

The hand positioner component modifies the conformation of the restrained hand through a set of mechanical linkages under motorized control.

In situ thermal stretching to modify the conformation of polyacrylonitrile (PAN) chains in quasicrystals and amorphous regions is carried out on PAN copolymer fibers prior to oxidative stabilization.

We have modified the conformation by opening the cycle and by changing the conformation of a Lys residue, and we have also mutated the aromatic side chains of the peptide.

By studying with the single molecule force spectroscopy (SMFS) methodology the mechanical behaviour of single biomolecules, we are learning how mechanical forces like those present in the extracellular space modify the conformation of proteins, possibly leading to functional switches.

Review of the previous art indicated that for fast inter-converting conformers, nucleation and polymorphism are favored but no effect is expected on crystal growth rate as crystal forces are expected to modify the conformation of the integrating species onto the crystal surface.

Although the concept of secondary dopant that modifies the conformation of PANI has been a major description for the role of m-cresol, the acidity of m-cresol also has been suggested as one of the crucial factors enhancing electron mobility of PANI.

We believe this makes MPS IIIC a good candidate for enzyme enhancement therapy [reviewed in 20], [21], where active site-specific inhibitors are used as pharmacological chaperones to modify the conformation of the mutant lysosomal enzymes usually retained and degraded in the ER in order to increase the level of the residual activity to a point sufficient to reverse the clinical phenotype.